Tom Loosli

机构：University of Zurich, University Hospital Zurich · ORCID：0000-0003-2049-3562

发表论文 30 篇 · 总被引 274 次 · h-index 7

代表论文

• HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis (2023 · The Lancet HIV · 被引 137)
• Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study (2025 · The Lancet Global Health · 被引 27)
• HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study (2024 · Clinical Infectious Diseases · 被引 19)
• Machine Learning-based Prediction of Active Tuberculosis in People With HIV Using Clinical Data (2025 · Clinical Infectious Diseases · 被引 16)
• Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study (2025 · Clinical Infectious Diseases · 被引 14)
• Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study (2025 · The Lancet HIV · 被引 7)